Investment bankers typically face a lot of obstacles getting companies to issue convertible bonds. They get a lot of strange looks from financial officers and directors. What are these things, anyway? Are they stocks or bonds? Is it a floor wax or...
BEDFORD, MA -- (Marketwired) -- 05/29/14 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in the following upcoming...
Insulet Corporation (PODD)
Q1 2014 Earnings Conference Call
May 7, 2014 5:00 PM ET
Duane DeSisto – President and Chief Executive Officer
Brian K. Roberts – Chief Financial Officer
By Alpha Gen Capital:
Insulet (PODD) is the maker of the well-liked and innovative "patch" pump for people diagnosed with type 1 diabetes. The company has sold their proprietary OmniPod System in the US since late 2005. They are responsible for...
WHITEFISH, MT -- (Marketwired) -- 03/20/14 --
Riding On Insulin, a nonprofit organization that empowers, activates and connects the global diabetes community through shared experience and action sports, and Insulet (NASDAQ: PODD), the leader...
Insulet Corporation (PODD)
Q4 2013 Earnings Conference Call
February 28, 2014 5:00 PM ET
Brian Roberts – CFO
Duane DeSisto – President and CEO
Bill Plovanic – Canaccord Genuity, Inc.
BEDFORD, MA -- (Marketwired) -- 02/27/14 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced financial results for the fourth quarter and full year...
BEDFORD, MA -- (Marketwired) -- 02/13/14 -- Insulet Corporation (NASDAQ: PODD), the leader in
tubeless insulin pump technology with its OmniPod® Insulin Management System, announced plans to release its financial results for the fourth...
By Bill Gunderson:
If you've read the news lately, you may have seen that Type I Diabetes is making headlines, again. And you were probably befuddled if you saw what I saw.
This news may come as a shock; living amidst too much cleanliness leads...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Insulet (PODD):
Insulet (PODD) is competing against Mini Med, a division of Medtronic, for the insulin delivery system segment. The product has a needle which is inserted until an audible sound is heard, then the needle withdraws leaving behind a tethlon tube. Insuline is dripped from the pod into the body via the tube. When the pod is low on the solution, more is added. This avoids the nasty needle sticks many diabetics loath.
The pod can be worn many places on the body and has no major tubes of complicated computer readouts, vs. the typical insulin pump.
Often a physician asks the patient to try wearing the pod while it drips saline. Uptake is high afterwards as the pod is so comfortable.
Per the CEO, Duane Desisto, they may have a pump company burried in a pod company. Meaning that other drugs may be delivered via the pod.